Brussels South Charleroi BioPark Launches Website

September 5th 2019

New website and corporate identity reflect focused international offering to support company growth from innovative start-ups through to global players in Life Sciences

Charleroi, Belgium, 5 September 2019 - Brussels South Charleroi BioPark, the science driven biopark in the heart of Europe, announces the launch of its new website and corporate identity. []

Originally founded by the Université Libre de Bruxelles (ULB) in 1999, the BioPark brings together a unique ecosystem of scientific, clinical and business expertise with world class facilities to create a perfect environment for drug research and development and across the broader life sciences space. The BioPark looks to support company growth from innovative start-ups through to global players in life sciences, providing services throughout a company’s life from inception through to providing ‘soft-landing’ support for international companies seeking a base in the heart of Europe.

Located in Charleroi, close to Brussels and international travel connections, the BioPark is already home to more than 2,000 highly skilled people from over 30 countries, 60 life sciences companies and three world-class research institutes. Companies in the BioPark are able to draw on one of Europe’s best developed financial ecosystems with access to capital from seed, via specialist venture capitalists and private equity through to the public equity markets combined with access to non-dilutive funding through national and regional grants.

Florence Bosco, Chief Executive Officer of Brussels South Charleroi BioPark Dev SA, commented: “Our new website and corporate identity reflect the world-class life sciences ecosystem in Belgium and specifically the benefits the BioPark can bring to companies at all stages of their development. The launch comes at the perfect moment with the importance of the sector in the city of Charleroi on the rise, creating a highly supportive environment, committed to the growth of the biotechnology sector. We are looking forward to continuing to nurture the companies already onsite and the next generation of start-ups as well as becoming the biopark of choice for global life sciences companies looking for the ideal base from which to grow in Europe.”

Michel Coulon, Chief Executive Officer of ULB Charleroi Campus, said: “The BioPark truly has science at its heart: companies benefit from a highly qualified pool of talent and access to cutting-edge technology platforms providing R&D services; our students and researchers have the opportunity to collaborate with innovative companies working at the forefront of the world’s life sciences industry. This close interaction drives the continuous development of our scientific programs and creates an ideal environment for the growth of successful companies.”

- Ends -

For further details please contact: Brussels South Charleroi BioPark Florence Bosco, CEO BioPark Dev SA +32 71 91 99 53

About Brussels South Charleroi BioPark

Brussels South Charleroi Biopark is a science-driven biopark at the heart of Europe dedicated to innovation and economic development with a mission to support company growth from start-up through to global players in life sciences. The Biopark is home to over 2,000 skilled people from over 30 countries, 60 life science companies, 15 clinical trial sites and three world-class research institutes (Institute for Medical and Molecular Biology (IBMM), the Center for Medical and Molecular Imaging (CMMI) and the Institute for Medical Immunology (IMI)). The BioPark provides a full range of real estate services and solutions from the Labhotel which provides shared lab space to greenfield development opportunities. The BioPark Incubator has been involved in the creation and development of more than 40 spin-offs in the past 10 years and provides support in establishing innovative companies including access to capital. Visit the full website at